Results 141 to 150 of about 113,965,924 (221)

A human H5N1 influenza virus expressing bioluminescence for evaluating viral infection and identifying therapeutic interventions

Summary: A multistate outbreak of highly pathogenic avian influenza virus (HPAIV) H5N1 in the United States dairy cattle was first reported on March 2024, followed by a zoonotic cattle-to-human virus transmission to a dairy farm worker in Texas.
García-Sastre, Adolfo, Mahmoud Bayoumi, Ahmed Mostafa, Ramya S. Barre, Joshua D. Castro, Barre, Ramya S., Aitor Nogales, Cupic, Anastasija, Castro, Esteban M., Bayoumi, Mahmoud, Escobedo, Ruby A., Anderson, Timothy J C, Adolfo García-Sastre, Carrion, Ricardo, Martínez-Sobrido, Luis, Ye, Chengin, Nathaniel Jackson, Nogales, Aitor, Ruby A. Escobedo, Castro, Joshua D., Chengin Ye, Ricardo Carrion, Jr., Platt, Roy N., Roy N. Platt, Esteban M. Castro, Anastasija Cupic, Mostafa, Ahmed, Luis Martinez-Sobrido, Michal Gazi, Timothy J.C. Anderson, Gazi, Michal, Jackson, Nathaniel   +31 more
core   +1 more source

Highly efficient intranasal H5N1 vaccine based on a safe vesicular stomatitis virus (VSV) vector. [PDF]

Signal Transduct Target Ther
Liang Z, Zhang M, Zhang J, Chen H, Chen J, Tang C, Tong J, Wu X, Liu S, Nie L, Li Q, Nie J, Lu S, Huang W, Wang Y.   +14 more
europepmc   +1 more source

Genomic detection of highly pathogenic avian influenza H5N1 in Antarctic seabirds reveals connectivity with South American viral lineages. [PDF]

Braz J Microbiol
Timm FCB, Gasparetto R, Côrrea ML, Melgarejo AS, Paredes-Galarza BS, Stone NV, Pizarro EJ, Mejías G, Lucca CP, Grazini-Capelin I, Pereira FM, Santos LG, Bermann T, Prandi BA, Violet-Lozano LM, Oliveira MT, Krüger L, Franco AC.   +17 more
europepmc   +1 more source

Protective Efficacy Evaluation of Various Inactivated Vaccines Against the Newly Circulated Highly Pathogenic Avian Influenza Virus H5N1 of Clade 2.3.4.4b in Pekin Ducks. [PDF]

Viruses
Shosha EAEM, Eldaghayes I, Ali AAH, Senosy Ali W, Elhayani EH.   +4 more
europepmc   +1 more source

Virology [PDF]

Influenza A (H5N1) viruses continue to pose a public health threat. As inactivated H5N1 vaccines are poorly immunogenic, adjuvants are needed to improve the immunogenicity of H5N1 vaccine in humans.

core  

Protective effect of A(H5N8) stockpiled vaccine against a virus genetically identical to a human isolate of bovine A(H5N1) influenza virus. [PDF]

EBioMedicine
Uraki R, Kiso M, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Imai M, Kawaoka Y.   +6 more
europepmc   +1 more source

Seroprevalence of Influenza A(H5N1) Virus in Domestic Cats at Epicenter of Dairy Cattle Outbreaks, California, USA, 2024-2026. [PDF]

Emerg Infect Dis
Bemis IG, Shittu I, Gomez JF, Fadaka EA, Perez S, Gray GC, Coleman KK.   +6 more
europepmc   +1 more source

Influenza type A (H5N1) virus infection [İnfluenza ti?p a (H5N1) vi?rus enfeksi?yonu]

, 2007
Influenza type A viruses have conserved their actuality and importance during history with their special respect of genetic variations and global pandemics.
Engin A.
core  

From fragmentation to coordination: strengthening One Health research to support H5N1 preparedness in Cambodia. [PDF]

IJID Reg
Puth S, Sagaon-Teyssier L, Chhoung C, Dary C, Khuon D, Seang K, Saphonn V.   +6 more
europepmc   +1 more source

Comparison of the adjuvant effect of AS01, AS03 and alum on the immune response to GMP-grade H5N1 antigen in guinea pigs. [PDF]

Sci Rep
Eckhardt E, Friedrich J, Lange W, Sehl-Ewert J, Harder T, Teifke J, van Zandbergen G, Bastian M.   +7 more
europepmc   +1 more source